VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer. Cancer Med. 2021 06; 10(11):3565-3574.
View in:
PubMed
subject areas
Adolescent
Adult
Age Factors
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating
Antineoplastic Combined Chemotherapy Protocols
Cardiotoxicity
Cardiovascular Diseases
Child
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Dacarbazine
Doxorubicin
Female
Heart
Humans
Male
Middle Aged
Multivariate Analysis
Neoplasm Recurrence, Local
Ovarian Neoplasms
Polyethylene Glycols
Product Surveillance, Postmarketing
Retrospective Studies
Sarcoma
Soft Tissue Neoplasms
Stroke Volume
Ventricular Function, Left
Young Adult
authors with profiles
SHREYASKUMAR PATEL
ROBERT COLEMAN